Fintepla

Fenfluramine · UCB, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Fintepla, covering 2020-06-25 to 2026-06-08. Get the full timeline:

Most recent: EMA Authorised: Fintepla (fenfluramine hydrochloride) — UCB Pharma S.A.